Exane Derivatives’s Progyny PGNY Stock Holding History

Exane Derivatives’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$38.8K	Hold	1,336	–	–	0.02%	330
2022 Q1	$68.7K	Buy	+1,336	New	+$57.2K	0.02%	527

Other funds holding PGNY

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Exane Derivatives's PGNY Position: Q2 2022 in Review

Exane Derivatives held its Progyny (PGNY) position steady in Q2 2022 at 1,336 shares worth $38.8K. The position accounts for 0.02% of the portfolio, ranked #330.

Exane Derivatives first reported a position in PGNY in Q1 2022 and has held it in 2 quarters since. The position peaked at $68.7K in Q1 2022. 246 funds tracked by Wall St. Rank hold PGNY as of Q2 2022.

Exane Derivatives held 1,336 shares of Progyny worth $38.8K as of Q2 2022.
Exane Derivatives left its Progyny share count unchanged in Q2 2022.
Progyny made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #330 holding.
Exane Derivatives first reported a position in Progyny in Q1 2022 and has held it in 2 quarters since.
Exane Derivatives's Progyny position peaked at $68.7K in Q1 2022.
246 funds tracked by Wall St. Rank held Progyny as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.